An Ogier team led by Niamh Lalor, head of the firm's Jersey Investment Funds team, has advised life sciences-focused investment firm Medicxi on the launch of Medicxi III.
In a first and final close, Medicxi raised €400 million from more than 40 investors, including a significant number of new institutional limited partners. Medicxi III, which is established as a Jersey Expert Fund, will make equity and equity-related investments primarily in European and Europe-originated life sciences companies targeting primarily pre-clinical and clinical stage private companies. This brings the total amount raised by Medicxi in the last three years to over $1 billion.
Niamh said: "Congratulations to Medicxi on this successful and rapid fund raise. We are delighted to have worked with Medicxi since it completed its spin-out of the life sciences practice from Index Ventures to this, its third generation fund."
The Ogier team, which included senior associate Alexandra O'Grady and associate Emilie Rowson, worked with lead counsel Travers Smith on the launch.